Methylene Blue Dosing
Methylene Blue Dosing is a therapeutic protocol that specifies the administration regimen of methylene blue as a pharmacological agent, differentiated by its precise quantification, timing, and route of delivery to achieve targeted biochemical or neuroprotective effects in clinical or experimental contexts.
69
Publications
2.8K
Citations
406
Authors
152
Institutions
Publications per year
2017–2026
12
Parents
69
Andrea Alemany, Pere Millat-Martínez, Marc Corbacho‐Monné et al. · The Lancet Respiratory Medicine · 2022 · 85 citations · Full text
1–5 of 69
406
3
h-index
3
h-index
2
h-index
2
h-index
2
h-index
1–5 of 406
152
Kansas State University
Manhattan, United States
3 h-index
5 publications
129 citations
Istituti di Ricovero e Cura a Carattere Scientifico
Rome, Italy
3 h-index
4 publications
113 citations
Hôpital Bichat-Claude-Bernard
Paris, France
2 h-index
7 publications
622 citations
The University of Texas at Austin
Austin, United States
2 h-index
3 publications
116 citations
University of Pennsylvania
Philadelphia, United States
2 h-index
2 publications
50 citations
Mayo Clinic
Rochester, United States
2 h-index
4 publications
147 citations
Université Claude Bernard Lyon 1
Villeurbanne, France
2 h-index
3 publications
206 citations
Cosmo Pharmaceuticals (Ireland)
Dublin, Ireland
2 h-index
3 publications
65 citations
1–8 of 152
Repository · 9 publications · 200 citations
9
h-index
5 publications · 145 citations
5
h-index
5 publications · 419 citations
5
h-index
2 publications · 121 citations
2
h-index
2 publications · 60 citations
2
h-index
1–5